Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.
作者： James E. Frampton
DOI: 10.1007/S40265-015-0360-7
关键词:
摘要: … therapy for chronic gout, febuxostat does not require dosage … 6–12 months’ treatment with febuxostat at dosages approved for use … In conclusion, febuxostat is a well established …
springer.com
sci-hub.se 参考文章(45)
Gary E Ruoff, Michael A Becker, What do I need to know about gout Journal of Family Practice. ,vol. 59, ,(2010)
Kamatani Naoyuki, Fujimori Shin, Hada Toshikazu, Hosoya Tatsuo, Kohri Kenjiro, Nakamura Toshitaka, Ueda Takanori, Yamamoto Tetsuya, Yamanaka Hisashi, Matsuzawa Yuji, Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study Jcr-journal of Clinical Rheumatology. ,vol. 17, ,(2011) , 10.1097/RHU.0B013E31821D36DE
Brian Tomlinson, Febuxostat in the management of hyperuricemia and chronic gout: a review Therapeutics and Clinical Risk Management. ,vol. 4, pp. 1209- 1220 ,(2008) , 10.2147/TCRM.S3310
Robert L. Wortmann, Patricia A. MacDonald, Barbara Hunt, Robert L. Jackson, Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials Clinical Therapeutics. ,vol. 32, pp. 2386- 2397 ,(2010) , 10.1016/J.CLINTHERA.2011.01.008
Frances Rees, Michelle Hui, Michael Doherty, Optimizing current treatment of gout Nature Reviews Rheumatology. ,vol. 10, pp. 271- 283 ,(2014) , 10.1038/NRRHEUM.2014.32
Andrew Whelton, Patricia A. MacDonald, Solomon Chefo, Lhanoo Gunawardhana, Preservation of Renal Function during Gout Treatment with Febuxostat: A Quantitative Study Postgraduate Medicine. ,vol. 125, pp. 106- 114 ,(2013) , 10.3810/PGM.2013.01.2626
Davide Grassi, Roberto Pontremoli, Raffaella Bocale, Claudio Ferri, Giovambattista Desideri, Therapeutic approaches to chronic hyperuricemia and gout. Annual Review of Physiology. ,vol. 21, pp. 243- 250 ,(2014) , 10.1007/S40292-014-0051-6
Peng Ye, Shumin Yang, Wenlong Zhang, Qiong Lv, Qingfeng Cheng, Mei Mei, Ting Luo, Lulu Liu, Shumei Chen, Qifu Li, Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis. Clinical Therapeutics. ,vol. 35, pp. 180- 189 ,(2013) , 10.1016/J.CLINTHERA.2012.12.011
Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann, Patricia A. MacDonald, William A. Palo, Denise Eustace, Laurent Vernillet, Nancy Joseph-Ridge, Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout Arthritis & Rheumatism. ,vol. 52, pp. 916- 923 ,(2005) , 10.1002/ART.20935
Michael D. Mayer, Reza Khosravan, Laurent Vernillet, Jing-Tao Wu, Nancy Joseph-Ridge, Darcy J. Mulford, Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. American Journal of Therapeutics. ,vol. 12, pp. 22- 34 ,(2005) , 10.1097/00045391-200501000-00005